Request for Covid-19 Impact Assessment of this Report
The United States Anti-infectious Disease Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Anti-infectious Disease Drugs market, reaching US$ million by the year 2028. As for the Europe Anti-infectious Disease Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Anti-infectious Disease Drugs players cover Aridis Pharmaceuticals, AiCuris, Sandoz, and Anhui Jingfang Medical Industry Co.,Ltd, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-infectious Disease Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Antibacterial Drugs
Antifungal Drugs
Antiviral Drugs
Antiparasitic Drugs
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Institute of Medicine
Clinic
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Aridis Pharmaceuticals
AiCuris
Sandoz
Anhui Jingfang Medical Industry Co.,Ltd
Beijing Double-Crane Pharmaceutical Co., Ltd.
Abbott
Spero Therapeutics
Adlyfe, Inc.
Advanced Life Sciences Holdings, Inc.
Affinium Pharmaceuticals
APP Pharmaceuticals
Aquapharm Biodiscovery
Basilea Pharmaceutica AG
Biophage Pharma, Inc.
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anti-infectious Disease Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Anti-infectious Disease Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Anti-infectious Disease Drugs by Country/Region, 2017, 2022 & 2028
2.2 Anti-infectious Disease Drugs Segment by Type
2.2.1 Antibacterial Drugs
2.2.2 Antifungal Drugs
2.2.3 Antiviral Drugs
2.2.4 Antiparasitic Drugs
2.3 Anti-infectious Disease Drugs Sales by Type
2.3.1 Global Anti-infectious Disease Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Anti-infectious Disease Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Anti-infectious Disease Drugs Sale Price by Type (2017-2022)
2.4 Anti-infectious Disease Drugs Segment by Application
2.4.1 Hospital
2.4.2 Institute of Medicine
2.4.3 Clinic
2.4.4 Others
2.5 Anti-infectious Disease Drugs Sales by Application
2.5.1 Global Anti-infectious Disease Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Anti-infectious Disease Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Anti-infectious Disease Drugs Sale Price by Application (2017-2022)
3 Global Anti-infectious Disease Drugs by Company
3.1 Global Anti-infectious Disease Drugs Breakdown Data by Company
3.1.1 Global Anti-infectious Disease Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Anti-infectious Disease Drugs Sales Market Share by Company (2020-2022)
3.2 Global Anti-infectious Disease Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Anti-infectious Disease Drugs Revenue by Company (2020-2022)
3.2.2 Global Anti-infectious Disease Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Anti-infectious Disease Drugs Sale Price by Company
3.4 Key Manufacturers Anti-infectious Disease Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-infectious Disease Drugs Product Location Distribution
3.4.2 Players Anti-infectious Disease Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Anti-infectious Disease Drugs by Geographic Region
4.1 World Historic Anti-infectious Disease Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Anti-infectious Disease Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Anti-infectious Disease Drugs Annual Revenue by Geographic Region
4.2 World Historic Anti-infectious Disease Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Anti-infectious Disease Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Anti-infectious Disease Drugs Annual Revenue by Country/Region
4.3 Americas Anti-infectious Disease Drugs Sales Growth
4.4 APAC Anti-infectious Disease Drugs Sales Growth
4.5 Europe Anti-infectious Disease Drugs Sales Growth
4.6 Middle East & Africa Anti-infectious Disease Drugs Sales Growth
5 Americas
5.1 Americas Anti-infectious Disease Drugs Sales by Country
5.1.1 Americas Anti-infectious Disease Drugs Sales by Country (2017-2022)
5.1.2 Americas Anti-infectious Disease Drugs Revenue by Country (2017-2022)
5.2 Americas Anti-infectious Disease Drugs Sales by Type
5.3 Americas Anti-infectious Disease Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-infectious Disease Drugs Sales by Region
6.1.1 APAC Anti-infectious Disease Drugs Sales by Region (2017-2022)
6.1.2 APAC Anti-infectious Disease Drugs Revenue by Region (2017-2022)
6.2 APAC Anti-infectious Disease Drugs Sales by Type
6.3 APAC Anti-infectious Disease Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Anti-infectious Disease Drugs by Country
7.1.1 Europe Anti-infectious Disease Drugs Sales by Country (2017-2022)
7.1.2 Europe Anti-infectious Disease Drugs Revenue by Country (2017-2022)
7.2 Europe Anti-infectious Disease Drugs Sales by Type
7.3 Europe Anti-infectious Disease Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Anti-infectious Disease Drugs by Country
8.1.1 Middle East & Africa Anti-infectious Disease Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Anti-infectious Disease Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Anti-infectious Disease Drugs Sales by Type
8.3 Middle East & Africa Anti-infectious Disease Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-infectious Disease Drugs
10.3 Manufacturing Process Analysis of Anti-infectious Disease Drugs
10.4 Industry Chain Structure of Anti-infectious Disease Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-infectious Disease Drugs Distributors
11.3 Anti-infectious Disease Drugs Customer
12 World Forecast Review for Anti-infectious Disease Drugs by Geographic Region
12.1 Global Anti-infectious Disease Drugs Market Size Forecast by Region
12.1.1 Global Anti-infectious Disease Drugs Forecast by Region (2023-2028)
12.1.2 Global Anti-infectious Disease Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Anti-infectious Disease Drugs Forecast by Type
12.7 Global Anti-infectious Disease Drugs Forecast by Application
13 Key Players Analysis
13.1 Aridis Pharmaceuticals
13.1.1 Aridis Pharmaceuticals Company Information
13.1.2 Aridis Pharmaceuticals Anti-infectious Disease Drugs Product Offered
13.1.3 Aridis Pharmaceuticals Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Aridis Pharmaceuticals Main Business Overview
13.1.5 Aridis Pharmaceuticals Latest Developments
13.2 AiCuris
13.2.1 AiCuris Company Information
13.2.2 AiCuris Anti-infectious Disease Drugs Product Offered
13.2.3 AiCuris Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 AiCuris Main Business Overview
13.2.5 AiCuris Latest Developments
13.3 Sandoz
13.3.1 Sandoz Company Information
13.3.2 Sandoz Anti-infectious Disease Drugs Product Offered
13.3.3 Sandoz Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Sandoz Main Business Overview
13.3.5 Sandoz Latest Developments
13.4 Anhui Jingfang Medical Industry Co.,Ltd
13.4.1 Anhui Jingfang Medical Industry Co.,Ltd Company Information
13.4.2 Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Product Offered
13.4.3 Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Anhui Jingfang Medical Industry Co.,Ltd Main Business Overview
13.4.5 Anhui Jingfang Medical Industry Co.,Ltd Latest Developments
13.5 Beijing Double-Crane Pharmaceutical Co., Ltd.
13.5.1 Beijing Double-Crane Pharmaceutical Co., Ltd. Company Information
13.5.2 Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Product Offered
13.5.3 Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Beijing Double-Crane Pharmaceutical Co., Ltd. Main Business Overview
13.5.5 Beijing Double-Crane Pharmaceutical Co., Ltd. Latest Developments
13.6 Abbott
13.6.1 Abbott Company Information
13.6.2 Abbott Anti-infectious Disease Drugs Product Offered
13.6.3 Abbott Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Abbott Main Business Overview
13.6.5 Abbott Latest Developments
13.7 Spero Therapeutics
13.7.1 Spero Therapeutics Company Information
13.7.2 Spero Therapeutics Anti-infectious Disease Drugs Product Offered
13.7.3 Spero Therapeutics Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Spero Therapeutics Main Business Overview
13.7.5 Spero Therapeutics Latest Developments
13.8 Adlyfe, Inc.
13.8.1 Adlyfe, Inc. Company Information
13.8.2 Adlyfe, Inc. Anti-infectious Disease Drugs Product Offered
13.8.3 Adlyfe, Inc. Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Adlyfe, Inc. Main Business Overview
13.8.5 Adlyfe, Inc. Latest Developments
13.9 Advanced Life Sciences Holdings, Inc.
13.9.1 Advanced Life Sciences Holdings, Inc. Company Information
13.9.2 Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Product Offered
13.9.3 Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Advanced Life Sciences Holdings, Inc. Main Business Overview
13.9.5 Advanced Life Sciences Holdings, Inc. Latest Developments
13.10 Affinium Pharmaceuticals
13.10.1 Affinium Pharmaceuticals Company Information
13.10.2 Affinium Pharmaceuticals Anti-infectious Disease Drugs Product Offered
13.10.3 Affinium Pharmaceuticals Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Affinium Pharmaceuticals Main Business Overview
13.10.5 Affinium Pharmaceuticals Latest Developments
13.11 APP Pharmaceuticals
13.11.1 APP Pharmaceuticals Company Information
13.11.2 APP Pharmaceuticals Anti-infectious Disease Drugs Product Offered
13.11.3 APP Pharmaceuticals Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 APP Pharmaceuticals Main Business Overview
13.11.5 APP Pharmaceuticals Latest Developments
13.12 Aquapharm Biodiscovery
13.12.1 Aquapharm Biodiscovery Company Information
13.12.2 Aquapharm Biodiscovery Anti-infectious Disease Drugs Product Offered
13.12.3 Aquapharm Biodiscovery Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Aquapharm Biodiscovery Main Business Overview
13.12.5 Aquapharm Biodiscovery Latest Developments
13.13 Basilea Pharmaceutica AG
13.13.1 Basilea Pharmaceutica AG Company Information
13.13.2 Basilea Pharmaceutica AG Anti-infectious Disease Drugs Product Offered
13.13.3 Basilea Pharmaceutica AG Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Basilea Pharmaceutica AG Main Business Overview
13.13.5 Basilea Pharmaceutica AG Latest Developments
13.14 Biophage Pharma, Inc.
13.14.1 Biophage Pharma, Inc. Company Information
13.14.2 Biophage Pharma, Inc. Anti-infectious Disease Drugs Product Offered
13.14.3 Biophage Pharma, Inc. Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Biophage Pharma, Inc. Main Business Overview
13.14.5 Biophage Pharma, Inc. Latest Developments
14 Research Findings and Conclusion
Table 1. Anti-infectious Disease Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Anti-infectious Disease Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Antibacterial Drugs
Table 4. Major Players of Antifungal Drugs
Table 5. Major Players of Antiviral Drugs
Table 6. Major Players of Antiparasitic Drugs
Table 7. Global Anti-infectious Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 8. Global Anti-infectious Disease Drugs Sales Market Share by Type (2017-2022)
Table 9. Global Anti-infectious Disease Drugs Revenue by Type (2017-2022) & ($ million)
Table 10. Global Anti-infectious Disease Drugs Revenue Market Share by Type (2017-2022)
Table 11. Global Anti-infectious Disease Drugs Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global Anti-infectious Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 13. Global Anti-infectious Disease Drugs Sales Market Share by Application (2017-2022)
Table 14. Global Anti-infectious Disease Drugs Revenue by Application (2017-2022)
Table 15. Global Anti-infectious Disease Drugs Revenue Market Share by Application (2017-2022)
Table 16. Global Anti-infectious Disease Drugs Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global Anti-infectious Disease Drugs Sales by Company (2020-2022) & (K Units)
Table 18. Global Anti-infectious Disease Drugs Sales Market Share by Company (2020-2022)
Table 19. Global Anti-infectious Disease Drugs Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Anti-infectious Disease Drugs Revenue Market Share by Company (2020-2022)
Table 21. Global Anti-infectious Disease Drugs Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers Anti-infectious Disease Drugs Producing Area Distribution and Sales Area
Table 23. Players Anti-infectious Disease Drugs Products Offered
Table 24. Anti-infectious Disease Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Anti-infectious Disease Drugs Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Anti-infectious Disease Drugs Sales Market Share Geographic Region (2017-2022)
Table 29. Global Anti-infectious Disease Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Anti-infectious Disease Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Anti-infectious Disease Drugs Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Anti-infectious Disease Drugs Sales Market Share by Country/Region (2017-2022)
Table 33. Global Anti-infectious Disease Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Anti-infectious Disease Drugs Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Anti-infectious Disease Drugs Sales by Country (2017-2022) & (K Units)
Table 36. Americas Anti-infectious Disease Drugs Sales Market Share by Country (2017-2022)
Table 37. Americas Anti-infectious Disease Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Anti-infectious Disease Drugs Revenue Market Share by Country (2017-2022)
Table 39. Americas Anti-infectious Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 40. Americas Anti-infectious Disease Drugs Sales Market Share by Type (2017-2022)
Table 41. Americas Anti-infectious Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 42. Americas Anti-infectious Disease Drugs Sales Market Share by Application (2017-2022)
Table 43. APAC Anti-infectious Disease Drugs Sales by Region (2017-2022) & (K Units)
Table 44. APAC Anti-infectious Disease Drugs Sales Market Share by Region (2017-2022)
Table 45. APAC Anti-infectious Disease Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Anti-infectious Disease Drugs Revenue Market Share by Region (2017-2022)
Table 47. APAC Anti-infectious Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 48. APAC Anti-infectious Disease Drugs Sales Market Share by Type (2017-2022)
Table 49. APAC Anti-infectious Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 50. APAC Anti-infectious Disease Drugs Sales Market Share by Application (2017-2022)
Table 51. Europe Anti-infectious Disease Drugs Sales by Country (2017-2022) & (K Units)
Table 52. Europe Anti-infectious Disease Drugs Sales Market Share by Country (2017-2022)
Table 53. Europe Anti-infectious Disease Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Anti-infectious Disease Drugs Revenue Market Share by Country (2017-2022)
Table 55. Europe Anti-infectious Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 56. Europe Anti-infectious Disease Drugs Sales Market Share by Type (2017-2022)
Table 57. Europe Anti-infectious Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 58. Europe Anti-infectious Disease Drugs Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Anti-infectious Disease Drugs Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Anti-infectious Disease Drugs Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Anti-infectious Disease Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Anti-infectious Disease Drugs Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Anti-infectious Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Anti-infectious Disease Drugs Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Anti-infectious Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Anti-infectious Disease Drugs Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Anti-infectious Disease Drugs
Table 68. Key Market Challenges & Risks of Anti-infectious Disease Drugs
Table 69. Key Industry Trends of Anti-infectious Disease Drugs
Table 70. Anti-infectious Disease Drugs Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Anti-infectious Disease Drugs Distributors List
Table 73. Anti-infectious Disease Drugs Customer List
Table 74. Global Anti-infectious Disease Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Anti-infectious Disease Drugs Sales Market Forecast by Region
Table 76. Global Anti-infectious Disease Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Anti-infectious Disease Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Anti-infectious Disease Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Anti-infectious Disease Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Anti-infectious Disease Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Anti-infectious Disease Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Anti-infectious Disease Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Anti-infectious Disease Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Anti-infectious Disease Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Anti-infectious Disease Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Anti-infectious Disease Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Anti-infectious Disease Drugs Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Anti-infectious Disease Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Anti-infectious Disease Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Anti-infectious Disease Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Anti-infectious Disease Drugs Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Anti-infectious Disease Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Anti-infectious Disease Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 94. Aridis Pharmaceuticals Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Aridis Pharmaceuticals Anti-infectious Disease Drugs Product Offered
Table 96. Aridis Pharmaceuticals Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. Aridis Pharmaceuticals Main Business
Table 98. Aridis Pharmaceuticals Latest Developments
Table 99. AiCuris Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. AiCuris Anti-infectious Disease Drugs Product Offered
Table 101. AiCuris Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. AiCuris Main Business
Table 103. AiCuris Latest Developments
Table 104. Sandoz Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Sandoz Anti-infectious Disease Drugs Product Offered
Table 106. Sandoz Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. Sandoz Main Business
Table 108. Sandoz Latest Developments
Table 109. Anhui Jingfang Medical Industry Co.,Ltd Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Product Offered
Table 111. Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. Anhui Jingfang Medical Industry Co.,Ltd Main Business
Table 113. Anhui Jingfang Medical Industry Co.,Ltd Latest Developments
Table 114. Beijing Double-Crane Pharmaceutical Co., Ltd. Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Product Offered
Table 116. Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 117. Beijing Double-Crane Pharmaceutical Co., Ltd. Main Business
Table 118. Beijing Double-Crane Pharmaceutical Co., Ltd. Latest Developments
Table 119. Abbott Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Abbott Anti-infectious Disease Drugs Product Offered
Table 121. Abbott Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 122. Abbott Main Business
Table 123. Abbott Latest Developments
Table 124. Spero Therapeutics Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 125. Spero Therapeutics Anti-infectious Disease Drugs Product Offered
Table 126. Spero Therapeutics Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 127. Spero Therapeutics Main Business
Table 128. Spero Therapeutics Latest Developments
Table 129. Adlyfe, Inc. Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 130. Adlyfe, Inc. Anti-infectious Disease Drugs Product Offered
Table 131. Adlyfe, Inc. Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 132. Adlyfe, Inc. Main Business
Table 133. Adlyfe, Inc. Latest Developments
Table 134. Advanced Life Sciences Holdings, Inc. Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 135. Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Product Offered
Table 136. Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 137. Advanced Life Sciences Holdings, Inc. Main Business
Table 138. Advanced Life Sciences Holdings, Inc. Latest Developments
Table 139. Affinium Pharmaceuticals Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 140. Affinium Pharmaceuticals Anti-infectious Disease Drugs Product Offered
Table 141. Affinium Pharmaceuticals Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 142. Affinium Pharmaceuticals Main Business
Table 143. Affinium Pharmaceuticals Latest Developments
Table 144. APP Pharmaceuticals Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 145. APP Pharmaceuticals Anti-infectious Disease Drugs Product Offered
Table 146. APP Pharmaceuticals Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 147. APP Pharmaceuticals Main Business
Table 148. APP Pharmaceuticals Latest Developments
Table 149. Aquapharm Biodiscovery Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 150. Aquapharm Biodiscovery Anti-infectious Disease Drugs Product Offered
Table 151. Aquapharm Biodiscovery Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 152. Aquapharm Biodiscovery Main Business
Table 153. Aquapharm Biodiscovery Latest Developments
Table 154. Basilea Pharmaceutica AG Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 155. Basilea Pharmaceutica AG Anti-infectious Disease Drugs Product Offered
Table 156. Basilea Pharmaceutica AG Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 157. Basilea Pharmaceutica AG Main Business
Table 158. Basilea Pharmaceutica AG Latest Developments
Table 159. Biophage Pharma, Inc. Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 160. Biophage Pharma, Inc. Anti-infectious Disease Drugs Product Offered
Table 161. Biophage Pharma, Inc. Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 162. Biophage Pharma, Inc. Main Business
Table 163. Biophage Pharma, Inc. Latest Developments
List of Figures
Figure 1. Picture of Anti-infectious Disease Drugs
Figure 2. Anti-infectious Disease Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-infectious Disease Drugs Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Anti-infectious Disease Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Anti-infectious Disease Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Antibacterial Drugs
Figure 10. Product Picture of Antifungal Drugs
Figure 11. Product Picture of Antiviral Drugs
Figure 12. Product Picture of Antiparasitic Drugs
Figure 13. Global Anti-infectious Disease Drugs Sales Market Share by Type in 2021
Figure 14. Global Anti-infectious Disease Drugs Revenue Market Share by Type (2017-2022)
Figure 15. Anti-infectious Disease Drugs Consumed in Hospital
Figure 16. Global Anti-infectious Disease Drugs Market: Hospital (2017-2022) & (K Units)
Figure 17. Anti-infectious Disease Drugs Consumed in Institute of Medicine
Figure 18. Global Anti-infectious Disease Drugs Market: Institute of Medicine (2017-2022) & (K Units)
Figure 19. Anti-infectious Disease Drugs Consumed in Clinic
Figure 20. Global Anti-infectious Disease Drugs Market: Clinic (2017-2022) & (K Units)
Figure 21. Anti-infectious Disease Drugs Consumed in Others
Figure 22. Global Anti-infectious Disease Drugs Market: Others (2017-2022) & (K Units)
Figure 23. Global Anti-infectious Disease Drugs Sales Market Share by Application (2017-2022)
Figure 24. Global Anti-infectious Disease Drugs Revenue Market Share by Application in 2021
Figure 25. Anti-infectious Disease Drugs Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Anti-infectious Disease Drugs Revenue Market Share by Company in 2021
Figure 27. Global Anti-infectious Disease Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Anti-infectious Disease Drugs Revenue Market Share by Geographic Region in 2021
Figure 29. Global Anti-infectious Disease Drugs Sales Market Share by Region (2017-2022)
Figure 30. Global Anti-infectious Disease Drugs Revenue Market Share by Country/Region in 2021
Figure 31. Americas Anti-infectious Disease Drugs Sales 2017-2022 (K Units)
Figure 32. Americas Anti-infectious Disease Drugs Revenue 2017-2022 ($ Millions)
Figure 33. APAC Anti-infectious Disease Drugs Sales 2017-2022 (K Units)
Figure 34. APAC Anti-infectious Disease Drugs Revenue 2017-2022 ($ Millions)
Figure 35. Europe Anti-infectious Disease Drugs Sales 2017-2022 (K Units)
Figure 36. Europe Anti-infectious Disease Drugs Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Anti-infectious Disease Drugs Sales 2017-2022 (K Units)
Figure 38. Middle East & Africa Anti-infectious Disease Drugs Revenue 2017-2022 ($ Millions)
Figure 39. Americas Anti-infectious Disease Drugs Sales Market Share by Country in 2021
Figure 40. Americas Anti-infectious Disease Drugs Revenue Market Share by Country in 2021
Figure 41. United States Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Anti-infectious Disease Drugs Sales Market Share by Region in 2021
Figure 46. APAC Anti-infectious Disease Drugs Revenue Market Share by Regions in 2021
Figure 47. China Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Anti-infectious Disease Drugs Sales Market Share by Country in 2021
Figure 54. Europe Anti-infectious Disease Drugs Revenue Market Share by Country in 2021
Figure 55. Germany Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Anti-infectious Disease Drugs Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Anti-infectious Disease Drugs Revenue Market Share by Country in 2021
Figure 62. Egypt Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Anti-infectious Disease Drugs in 2021
Figure 68. Manufacturing Process Analysis of Anti-infectious Disease Drugs
Figure 69. Industry Chain Structure of Anti-infectious Disease Drugs
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...